Click here to read more Quest articles. print | Print this page
From Spring 2014 Quest

Prostate cancer research has produced many new drugs, treatments, and biomarkers that are available to patients today, and many others are in the pipeline. I believe that the genetic revolution will usher in a new era of prostate cancer management that will ultimately justify Russ's commitment and efforts.

–Dr. Catalona

The URF pays tribute to Russ Gould, who passed away on December 21, 2013. After being diagnosed with prostate cancer in 1997, Mr. Gould worked tirelessly to support and promote prostate cancer programs both locally and nationally, affecting thousands of men and their families. As a Specialized Program of Research Excellence (SPORE) patient advocate at Northwestern, he helped create important clinical trials and make them available to the prostate cancer community. Mr. Gould freely shared his insights into prostate cancer with Wellness Place and through his involvement with Us TOO as a lecturer and chapter leader. Both organizations are committed to providing vital support free of charge to prostate cancer survivors and their families. He also was one of the founding members of the SEA Blue Prostate Cancer Walk/Run, which has raised over $2 million for prostate cancer support, education and awareness.

The URF extends condolences to the family of Russ Gould.

Dr. Catalona and others at the SEA Blue Prostate Cancer Walk/Run. (left to right) Phillip Cooper (Research assistant), Sriram Rangarajan (Research assistant), Robin Leikin (Scientific Program Director of the Lurie Cancer Center), Jan Catalona, Dr. Catalona


Close this window